Songmei Geng Selected Research

proadrenomedullin (9-20)

12/2021

Action of substance P and PAMP(9-20) on different excitation sites of MRGPRX2 induces differences in mast cell activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Songmei Geng Research Topics

Disease

10	Neoplasms (Cancer) 01/2022 - 01/2009
5	Hypersensitivity (Allergy) 05/2022 - 09/2019
5	Melanoma (Melanoma, Malignant) 01/2022 - 01/2009
4	Inflammation (Inflammations) 01/2022 - 09/2019
4	Dermatitis 01/2022 - 09/2019
4	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022 - 02/2008
3	Autoimmune Diseases (Autoimmune Disease) 10/2022 - 01/2019
2	Contact Dermatitis (Eczema, Contact) 01/2022 - 09/2019
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2022 - 01/2019
2	Infections 06/2021 - 01/2021
2	type 2C Congenital disorder of glycosylation 04/2020 - 09/2019
2	Acne Vulgaris 09/2018 - 04/2016
1	Vitiligo 10/2022
1	Port-Wine Stain (Nevus Flammeus) 09/2022
1	Anaphylaxis (Anaphylactic Shock) 05/2022
1	Immediate Hypersensitivity 05/2022
1	Orofacial Granulomatosis 01/2022
1	Tinea (Ringworm) 01/2022
1	Acute Generalized Exanthematous Pustulosis 01/2022
1	Mycoses (Diseases, Fungus) 01/2022
1	Chronic Urticaria 11/2021
1	Chronic Inducible Urticaria 11/2021
1	Phototoxic Dermatitis (Phototoxicity) 06/2021
1	Dysbiosis 01/2021
1	Bullous Pemphigoid (Pemphigoid) 01/2021
1	Pemphigus and fogo selvagem 01/2021
1	Skin Diseases (Skin Disease) 01/2019
1	Pemphigus (Pemphigus Vulgaris) 01/2019
1	Cicatrix (Scar) 09/2018
1	Cheilitis 09/2018
1	Xerostomia 09/2018

Drug/Important Bio-Agent (IBA)

4	CytokinesIBA 05/2022 - 09/2019
3	Therapeutic UsesIBA 05/2022 - 06/2021
3	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2022 - 01/2009
3	AutoantibodiesIBA 01/2021 - 01/2019
3	Small Interfering RNA (siRNA)IBA 04/2020 - 01/2017
3	Cadherins (E-Cadherin)IBA 01/2017 - 02/2008
2	Proteins (Proteins, Gene)FDA Link 10/2022 - 01/2017
2	Tryptases (Tryptase)IBA 01/2022 - 12/2021
2	GTP-Binding Proteins (G-Protein)IBA 01/2022 - 09/2019
2	AntigensIBA 01/2022 - 01/2019
2	Adalimumab (Humira)FDA Link 01/2022 - 01/2022
2	16S Ribosomal RNAIBA 01/2022 - 01/2021
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2022
2	Biological ProductsIBA 01/2022 - 01/2013
2	Hexosaminidases (Hexosaminidase)IBA 04/2020 - 09/2019
2	Imiquimod (Aldara)FDA LinkGeneric 04/2020 - 10/2013
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 04/2020 - 09/2019
2	Histamine (Histamine Dihydrochloride)FDA Link 09/2019 - 09/2019
2	Immunoglobulin E (IgE)IBA 09/2019 - 01/2014
2	RetinoidsIBA 09/2019 - 01/2009
2	VimentinIBA 01/2017 - 05/2013
2	CateninsIBA 01/2017 - 05/2013
1	Melanins (Melanin)IBA 10/2022
1	LigandsIBA 10/2022
1	Toll-Like Receptors (Toll-Like Receptor)IBA 10/2022
1	LipopolysaccharidesIBA 10/2022
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 09/2022
1	hematoporphyrin monomethyl etherIBA 09/2022
1	LuteolinIBA 05/2022
1	dehydroandrographolideIBA 05/2022
1	Hair DyesIBA 01/2022
1	4-phenylenediamine (p-phenylenediamine)FDA Link 01/2022
1	Tuberculin (PPD)IBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Histones (Histone)IBA 01/2022
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2022
1	gamma Subunit Interferon-Stimulated Gene Factor 3 (Interferon Stimulated Gene Factor 3, gamma Subunit)IBA 01/2022
1	InterferonsIBA 01/2022
1	Biosimilar PharmaceuticalsIBA 01/2022
1	Lysine (L-Lysine)FDA Link 01/2022
1	aloe emodinIBA 01/2022
1	Prostaglandins AIBA 01/2022
1	CohesinsIBA 01/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	proadrenomedullin (9-20)IBA 12/2021
1	Omalizumab (Xolair)FDA Link 11/2021
1	Histamine Antagonists (Antihistamines)IBA 11/2021
1	Sincalide FDA Link 06/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	AutoantigensIBA 01/2021
1	AntibodiesIBA 01/2021
1	EpitopesIBA 01/2021
1	UbiquitinIBA 01/2021
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 01/2021
1	Complement System Proteins (Complement)IBA 01/2021
1	Pharmaceutical PreparationsIBA 09/2019
1	Eosine Yellowish-(YS) (Eosin)IBA 09/2019
1	CalciumIBA 09/2019
1	Thimerosal (Thiomersal)IBA 09/2019
1	Complement C3a (Complement 3a)IBA 01/2019
1	Complement C3 (C3 Complement)IBA 01/2019
1	AllergensIBA 01/2019
1	Isotretinoin (Accutane)FDA LinkGeneric 09/2018

Therapy/Procedure

4	Photochemotherapy (Photodynamic Therapy) 09/2022 - 01/2021
3	Therapeutics 09/2019 - 01/2013
2	Lasers (Laser) 09/2018 - 04/2016
1	Aftercare (After-Treatment) 01/2022
1	Duration of Therapy 11/2021
1	Precision Medicine 01/2021